Investing.com - PAVmed (NASDAQ: PAVM) reported fourth quarter EPS of $-0.990, $0.51 better than the analyst estimate of $-1.500. Revenue for the quarter came in at $1.01M versus the consensus estimate of $1.04M.
PAVmed's stock price closed at $1.92. It is down -1.540% in the last 3 months and down -70.540% in the last 12 months.
PAVmed saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See PAVmed's stock price’s past reactions to earnings here.
According to InvestingPro, PAVmed's Financial Health score is "weak performance".
Check out PAVmed's recent earnings performance, and PAVmed's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar